Annual Current Liabilities
$3.96 M
-$2.86 M-41.94%
December 31, 2023
Summary
- As of February 8, 2025, INTS annual total current liabilities is $3.96 million, with the most recent change of -$2.86 million (-41.94%) on December 31, 2023.
- During the last 3 years, INTS annual current liabilities has risen by +$2.61 million (+194.13%).
- INTS annual current liabilities is now -41.94% below its all-time high of $6.82 million, reached on December 31, 2022.
Performance
INTS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.32 M
-$887.00 K-27.68%
September 30, 2024
Summary
- As of February 8, 2025, INTS quarterly total current liabilities is $2.32 million, with the most recent change of -$887.00 thousand (-27.68%) on September 30, 2024.
- Over the past year, INTS quarterly current liabilities has stayed the same.
- INTS quarterly current liabilities is now -66.31% below its all-time high of $6.88 million, reached on March 31, 2023.
Performance
INTS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
INTS Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -41.9% | 0.0% |
3 y3 years | +194.1% | -66.3% |
5 y5 years | +250.9% | -66.3% |
INTS Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -41.9% | +6.4% | -66.3% | +220.0% |
5 y | 5-year | -41.9% | +250.9% | -66.3% | +220.0% |
alltime | all time | -41.9% | +250.9% | -66.3% | +220.0% |
Intensity Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.32 M(-27.7%) |
Jun 2024 | - | $3.20 M(+27.2%) |
Mar 2024 | - | $2.52 M(-36.4%) |
Dec 2023 | $3.96 M(-41.9%) | $3.96 M(+446.8%) |
Sep 2023 | - | $724.00 K(-76.3%) |
Jun 2023 | - | $3.06 M(-55.5%) |
Mar 2023 | - | $6.88 M(+0.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $6.82 M(+83.3%) | $6.82 M(+46.0%) |
Jun 2022 | - | $4.67 M(+6.9%) |
Mar 2022 | - | $4.37 M(+17.4%) |
Dec 2021 | $3.72 M(+176.4%) | - |
Dec 2021 | - | $3.72 M(-15.8%) |
Sep 2021 | - | $4.42 M(+228.5%) |
Dec 2020 | $1.35 M(+19.3%) | $1.35 M |
Dec 2019 | $1.13 M | - |
FAQ
- What is Intensity Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Intensity Therapeutics?
- What is Intensity Therapeutics annual current liabilities year-on-year change?
- What is Intensity Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Intensity Therapeutics?
- What is Intensity Therapeutics quarterly current liabilities year-on-year change?
What is Intensity Therapeutics annual total current liabilities?
The current annual current liabilities of INTS is $3.96 M
What is the all time high annual current liabilities for Intensity Therapeutics?
Intensity Therapeutics all-time high annual total current liabilities is $6.82 M
What is Intensity Therapeutics annual current liabilities year-on-year change?
Over the past year, INTS annual total current liabilities has changed by -$2.86 M (-41.94%)
What is Intensity Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of INTS is $2.32 M
What is the all time high quarterly current liabilities for Intensity Therapeutics?
Intensity Therapeutics all-time high quarterly total current liabilities is $6.88 M
What is Intensity Therapeutics quarterly current liabilities year-on-year change?
Over the past year, INTS quarterly total current liabilities has changed by $0.00 (0.00%)